FDA puts new limits on Johnson & Johnson vaccine due to rare blood clotting condition

Health officials have detected 60 cases of the rare blood clotting condition TTS, nine of which have been fatal

FDA puts new limits on Johnson & Johnson vaccine due to rare blood clotting condition | Fox Business

Only individuals who are 18 years of age and older who "would otherwise not receive a COVID-19 vaccine" due to availability or their choice should now take Johnson & Johnson's one-shot regiment. 

The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).